The clinical strategy of precisely managing the breakdown products, or metabolites, of androgens like testosterone and DHEA, rather than simply measuring the parent hormone. This practice ensures that androgens are metabolized via favorable pathways, minimizing the formation of potentially problematic or less beneficial downstream compounds. Achieving this balance is crucial for mitigating side effects and maximizing the anabolic and neurocognitive benefits of androgen therapy.
Origin
This specialized focus arose with the advent of advanced urinary hormone testing, which allows for the quantification of specific androgen breakdown products like 5α-reductase and 5β-reductase metabolites. The clinical realization that a healthy parent hormone level does not guarantee a healthy metabolic profile drove the development of this precision-focused therapeutic strategy.
Mechanism
The mechanism centers on utilizing specific nutritional cofactors, enzyme modulators, and occasionally pharmaceutical agents to influence the activity of metabolic enzymes like aromatase and 5α-reductase. By steering the metabolic pathway, for instance, toward the less potent 5β-metabolites and away from the more potent 5α-metabolites like dihydrotestosterone, clinicians can achieve the desired therapeutic outcome while minimizing adverse effects on hair, skin, and prostate tissue.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.